Cargando…
Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19
Neurological long-term sequelae are increasingly considered an important challenge in the recent COVID-19 pandemic. However, most evidence for neurological symptoms after SARS-CoV-2 infection and central nervous system invasion of the virus stems from individuals severely affected in the acute phase...
Autores principales: | Borsche, Max, Reichel, Dirk, Fellbrich, Anja, Lixenfeld, Anne S., Rahmöller, Johann, Vollstedt, Eva-Juliane, Föh, Bandik, Balck, Alexander, Klein, Christine, Ehlers, Marc, Moser, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214919/ https://www.ncbi.nlm.nih.gov/pubmed/34148546 http://dx.doi.org/10.1186/s42466-021-00135-y |
Ejemplares similares
-
Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study – a prospective population-based cohort study
por: Balck, Alexander, et al.
Publicado: (2022) -
Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
por: Föh, Bandik, et al.
Publicado: (2021) -
Transition to endemic: 2-year SARS-CoV-2 surveillance follow-up of the ELISA cohort
por: Föh, Bandik, et al.
Publicado: (2023) -
One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk
por: Klein, Christine, et al.
Publicado: (2022) -
Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients
por: Schmelter, Franziska, et al.
Publicado: (2021)